Immobiliare Grande Distribuzione SIIQ Valuation
Is IF81 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IF81 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IF81 (€2.27) is trading below our estimate of fair value (€3.51)
Significantly Below Fair Value: IF81 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IF81?
Key metric: As IF81 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is IF81's PS Ratio? | |
|---|---|
| PS Ratio | 1.7x |
| Sales | €146.76m |
| Market Cap | €254.34m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.3x |
| Enterprise Value/EBITDA | 10.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does IF81's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.4x | ||
DKG Deutsche Konsum REIT-AG | 1.3x | -12.7% | €141.7m |
HABA Hamborner REIT | 5x | 1.7% | €525.5m |
FVI Fair Value REIT-AG | 2.3x | n/a | €54.7m |
AOX alstria office REIT-AG | 5.1x | -1.5% | €1.2b |
IF81 Immobiliare Grande Distribuzione SIIQ | 1.7x | -2.2% | €254.3m |
Price-To-Sales vs Peers: IF81 is good value based on its Price-To-Sales Ratio (1.7x) compared to the peer average (3.4x).
Price to Sales Ratio vs Industry
How does IF81's PS Ratio compare vs other companies in the European Retail REITs Industry?
| 0 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: IF81 is good value based on its Price-To-Sales Ratio (1.7x) compared to the European Retail REITs industry average (5.7x).
Price to Sales Ratio vs Fair Ratio
What is IF81's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.7x |
| Fair PS Ratio | 5.2x |
Price-To-Sales vs Fair Ratio: IF81 is good value based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (5.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €2.27 | €2.54 +12.0% | 5.5% | €2.65 | €2.30 | n/a | 4 |
| Nov ’25 | €2.49 | €2.54 +1.9% | 5.5% | €2.65 | €2.30 | n/a | 4 |
| Oct ’25 | €2.50 | €2.36 -5.5% | 12.6% | €2.65 | €1.90 | n/a | 4 |
| Sep ’25 | €2.46 | €2.36 -4.0% | 12.6% | €2.65 | €1.90 | n/a | 4 |
| Aug ’25 | €1.93 | €2.16 +12.3% | 15.6% | €2.65 | €1.80 | n/a | 4 |
| Jul ’25 | €1.74 | €2.16 +24.1% | 15.6% | €2.65 | €1.80 | n/a | 4 |
| Jun ’25 | €1.97 | €2.16 +9.9% | 15.6% | €2.65 | €1.80 | n/a | 4 |
| May ’25 | €1.61 | €2.39 +48.7% | 24.0% | €3.20 | €1.80 | n/a | 4 |
| Apr ’25 | €1.48 | €2.39 +61.5% | 24.0% | €3.20 | €1.80 | n/a | 4 |
| Mar ’25 | €1.67 | €2.58 +55.1% | 20.6% | €3.20 | €1.90 | n/a | 3 |
| Feb ’25 | €2.15 | €2.68 +25.1% | 15.2% | €3.20 | €2.20 | n/a | 3 |
| Jan ’25 | €2.28 | €2.66 +16.8% | 13.4% | €3.20 | €2.20 | n/a | 4 |
| Dec ’24 | €2.13 | €2.85 +33.8% | 16.7% | €3.40 | €2.20 | n/a | 4 |
| Nov ’24 | €1.95 | €2.85 +46.2% | 16.7% | €3.40 | €2.20 | €2.49 | 4 |
| Oct ’24 | n/a | €3.00 0% | 10.5% | €3.40 | €2.60 | €2.50 | 4 |
| Sep ’24 | n/a | €3.00 0% | 10.5% | €3.40 | €2.60 | €2.46 | 4 |
| Aug ’24 | n/a | €3.28 0% | 5.9% | €3.50 | €3.00 | €1.93 | 4 |
| Jul ’24 | n/a | €3.28 0% | 5.9% | €3.50 | €3.00 | €1.74 | 4 |
| Jun ’24 | n/a | €3.28 0% | 5.9% | €3.50 | €3.00 | €1.97 | 4 |
| May ’24 | n/a | €3.28 0% | 5.9% | €3.50 | €3.00 | €1.61 | 4 |
| Apr ’24 | n/a | €3.28 0% | 5.9% | €3.50 | €3.00 | €1.48 | 4 |
| Mar ’24 | n/a | €3.38 0% | 3.2% | €3.50 | €3.20 | €1.67 | 4 |
| Feb ’24 | n/a | €4.08 0% | 20.0% | €5.20 | €3.20 | €2.15 | 4 |
| Jan ’24 | n/a | €4.43 0% | 12.1% | €5.20 | €3.70 | €2.28 | 4 |
| Dec ’23 | n/a | €4.43 0% | 12.1% | €5.20 | €3.70 | €2.13 | 4 |
| Nov ’23 | n/a | €4.68 0% | 7.2% | €5.20 | €4.30 | €1.95 | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Argan
€1.7b
Engages in designing, building, developing, owning, leasing, and managing logistical platforms in France.
871
€63.70
7D
-3.0%
1Y
-16.2%
Allied Properties Real Estate Investment Trust
CA$2.5b
Allied is a leading owner-operator of distinctive urban workspace in Canada's major cities.
5G8
CA$12.18
7D
-0.4%
1Y
1.7%
NSI
€376.7m
A specialist commercial property investor and the only listed real estate investment trust (REIT) focused on well-located offices in economic growth regions in The Netherlands.
N4RN
€19.46
7D
0%
1Y
12.4%